Biotech grants in the United States
Explore Biotech grants for companies in the United States. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from US innovation agencies, research funders and foundations, international programs open to applicants in the United States, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in the United States come first.
Showing 49-72 of 1,242 grants
DoW Toxic Exposures Clinical Trial Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds one clinical trial, at any scale, testing what helps a disease or condition linked to military-related toxic exposure.
DoW Toxic Exposures Investigator Initiated Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds basic-through-translational research on diseases linked to military-related toxic exposure, at almost any research stage short of a new clinical trial.
DoW Toxic Exposures Translational Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds translational research turning a promising idea about toxic-exposure illness into a real clinical application.
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention
๐บ๐ธNIH ยท United States
Funds stroke trials and biomarker studies run inside NIH's national StrokeNet โ with its coordinating centres doing recruitment and data.
BIRD General Program
๐บ๐ธBIRD Foundation ยท United States
Supports United States and Israel partners to jointly commercialize hi-tech innovation, including cybersecurity, life sciences, and manufacturing.
HEAL Initiative: Pain Research Enhancement Program (PREP)
๐บ๐ธNIH ยท United States
Funds basic and mechanistic pain research at institutions that receive little NIH funding, with students working on the project alongside the investigator.
NIH HEAL Initiative โ Open NOFOs
๐บ๐ธNIH ยท United States
Supports opioid, pain, and substance use disorder research in the NIH HEAL portfolio.
CFF/NIH R01 Unfunded Award
๐บ๐ธCFF ยท United States
Invests research teams and institutions for CFF NIH Unfunded Award in biotechnology and medical technology.
Damon Runyon Physician-Scientist Training Award
๐บ๐ธDamon Runyon ยท United States
Supports clinical physicians transitioning into full-time cancer laboratory research through physician-scientist training.
Damon Runyon Quantitative Biology Fellowship
๐บ๐ธDamon Runyon ยท United States
Provides students and early career scholars with mentoring support for Damon Runyon Quantitative Biology Fellowship in biotechnology, artificial intelligence, and medical technology.
NIOSH WTC Health Program โ R21 Exploratory Grant
๐บ๐ธNIOSH ยท United States
Funds exploratory clinical studies improving diagnostics and treatments from disaster-related conditions.
NIOSH WTC Health Program โ U01 Cooperative Research
๐บ๐ธNIOSH ยท United States
Funds clinical research into health outcomes linked to complex urban disasters.
The Genesis Mission: Transforming Science and Energy with AI
๐บ๐ธDOE SC ยท United States
Supports AI for science progress from early concept stages toward national-scale implementation.
AFRI Foundational and Applied Science
๐บ๐ธUSDA NIFA ยท United States
Supports agriculture innovation across plant health, bioenergy, food safety, and rural systems through USDA research grants and extension.
Innovation Fund Tax Credit Program
๐บ๐ธIEDA ยท United States
Provides investors with Iowa tax credits for placing capital into certified innovation funds that back early-stage local companies.
Oligonucleotide Toxicity (OligoTox) Open Data Challenge
๐บ๐ธNCATS ยท United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
ARPA-H SBIR/STTR
๐บ๐ธARPA-H ยท United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
NIH SBIR Direct-to-Phase II (Omnibus)
๐บ๐ธNIH ยท United States
Funds United States small businesses moving directly into major development when early biomedical feasibility is already established.
NIH SBIR Fast-Track (Omnibus)
๐บ๐ธNIH ยท United States
Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.
NIH SBIR Phase I (Omnibus)
๐บ๐ธNIH ยท United States
Funds United States small businesses advancing biomedical and behavioral-health innovations through early technical validation.
NIH SBIR Phase II (Omnibus)
๐บ๐ธNIH ยท United States
Funds United States small businesses advancing validated biomedical innovations through substantial full development execution.
NIH STTR Phase I (Omnibus)
๐บ๐ธNIH ยท United States
Funds United States small businesses partnering with nonprofit research institutions to validate biomedical ideas.
NIH STTR Phase II (Omnibus)
๐บ๐ธNIH ยท United States
Funds United States small-business and research-partner teams advancing biomedical projects already proven in early studies.
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
๐บ๐ธNIH ยท United States
Funds small clinical-trial research at undergraduate-focused colleges that get under $6 million a year from NIH.